Merck & Co. shifts its cancer drug development playbook, opting for targeted collaborations with Guardant Health and Eikon Therapeutics after walking away from a major acquisition. Analysts debate whether the stock's current price fully reflects its long-term pipeline potential.
Oracle's deepening role as TikTok's U.S. data guardian and its aggressive push into regulated AI sectors present a dual narrative of strategic growth and heightened operational scrutiny, following a service outage linked to its infrastructure.
A wave of protests and student walkouts swept across the United States on Friday, demanding the withdrawal of federal immigration agents from Minnesota following fatal shootings, as political tensions threaten a government shutdown.
Apple shares edged higher following a robust Q1 earnings report headlined by record iPhone revenue, yet the muted gains reflect Wall Street's growing focus on looming supply constraints and the company's strategic pivot to artificial intelligence.
The Trump administration has escalated pressure on Cuba by declaring a national emergency and threatening punitive tariffs on countries supplying it with oil, while simultaneously finalizing a reciprocal trade agreement with Guatemala aimed at bolstering Western Hemisphere supply chains.
A deep dive into the intrinsic value of Micro-Mechanics (Holdings) Ltd. (SGX:5DD) using a Discounted Cash Flow model suggests the stock is trading close to its estimated fair value of S$1.83, presenting a nuanced picture for investors.
High-performance computing specialist One Stop Systems secures a significant initial order from a major aerospace contractor for next-gen in-flight entertainment hardware, as its stock continues a remarkable year-long rally.
Ameris Bancorp's latest financial report reveals a dual narrative: robust net interest income and earnings per share, contrasted with a notable increase in loan charge-offs. While share buybacks and profitability metrics remain supportive, analysts are scrutinizing whether the stock's premium valuation is justified amidst emerging credit risks.
Citi analyst Geoff Meacham raised his price target on Bristol-Myers Squibb (BMY) to $60, citing a more favorable setup for the sector. The move comes as the drugmaker also announces a partnership with Microsoft to leverage AI for earlier lung cancer detection.
Private equity giant Thoma Bravo is exploring a sale of Imprivata, a key player in healthcare digital identity software, in a deal that could value the company at up to $7 billion, sources tell Reuters.
Cocoa futures have plunged to multi-year lows, pressured by a global surplus and weakening demand as high chocolate prices curb consumption. Analysts point to favorable harvests in West Africa and falling processing volumes as key factors extending the market's month-long decline.
New CMS reimbursement rates are pressuring Medicare Advantage profits, sending shares of Humana and CVS Health lower. We analyze whether the sell-off presents a buying opportunity for dividend investors or signals deeper structural challenges.
Wells Fargo updates its long-term valuation for American Electric Power (AEP), raising its price target to $140, as the utility secures a major fuel cell investment and a 20-year power purchase agreement for a new Wyoming facility.
Tunisian President Kais Saied has prolonged the nation's state of emergency for an additional 11 months, maintaining exceptional powers first enacted in 2015 following a deadly attack on presidential guards.
Panera Bread confirms a second major data security incident in two years, while Krispy Kreme agrees to a $1.6 million settlement over a 2024 breach, as the foodservice industry grapples with escalating cyber threats and consumer lawsuits.
Truist Securities adjusted its price target for American Healthcare REIT (NYSE: AHR) downward slightly, while affirming a Buy rating. The move comes as the firm reassesses its outlook for the broader REIT sector heading into 2026.
B. Riley analyst Craig Ellis has upgraded Rigetti Computing (NASDAQ: RGTI) from 'Neutral' to 'Buy', maintaining a $35 price target. The upgrade follows the company's announcement of an $8.4 million order to supply a 108-qubit quantum computer to India's premier R&D agency, C-DAC, providing clearer visibility into its 2026 commercial trajectory.
Facing stiff competition, Verizon is deploying AI at scale and restructuring its operations—funded partly by recent layoffs—to simplify customer interactions and rebuild loyalty in a saturated market.
With low adoption rates for brokerage 'trusted contacts,' regulators are considering a simple name change to 'emergency contact' to reduce confusion, ease client concerns, and strengthen protections against financial exploitation.
Investors face a classic choice between AbbVie's steady dividends and Abivax's high-risk, high-reward potential as both target lucrative immunology markets.
